Skip to main content
. Author manuscript; available in PMC: 2017 Jan 30.
Published in final edited form as: J Am Coll Cardiol. 2015 Mar 17;65(10):999–1009. doi: 10.1016/j.jacc.2014.12.043

Figure 1. CONSORT Diagram.

Figure 1

Participants were randomized after consenting for study participation and undergoing eligibility testing. Potentially eligible study participants were screened at the discretion of the study site. The proportion that did not expire, withdraw consent, exit the study, or were not lost to follow-up before completion of the 18-month follow-up was 93/111 (84%). Of the 93 who remained in the study for the entire 18 months of follow-up, treadmill test data were available for 79/111 (71%) at 18 months. Of the 14 who remained in the study for the duration of follow-up, but did not undergo the treadmill test at 18 months, there were 9 in ST, 2 in SE, and 3 in OMC. The reasons for 9 ST participants missing PWT were: could not be contacted (1), comorbid condition (recent laminectomy in 1); out of 2-week window (2), and refused (5, 3 of whom had crossed over to structured exercise). The reasons for 3 OMC participants missing PWT were: comorbid condition (unknown, 1); no show (2). The reasons for 2 SE participants missing PWT were: refused (1) and unknown (1). Of the 14 patients who did not have the 18-month PWT, 7 had other 18-month endpoints collected, and 13 had QOL data collected by telephone. All study participants were confirmed to be alive at the 18-month follow-up interval, except for 1 person in SE who expired before the 6-month follow-up.